{"id":58917,"date":"2026-03-06T13:25:11","date_gmt":"2026-03-06T05:25:11","guid":{"rendered":"https:\/\/flcube.com\/?p=58917"},"modified":"2026-03-06T13:25:11","modified_gmt":"2026-03-06T05:25:11","slug":"boan-biotech-partners-with-dp-technology-on-ai4s-drug-discovery-antibody-adc-and-tce-pipeline-acceleration","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=58917","title":{"rendered":"Boan Biotech Partners with DP Technology on AI4S Drug Discovery \u2013 Antibody, ADC, and TCE Pipeline Acceleration"},"content":{"rendered":"\n<p><strong>Shandong Boan Biotechnology Co., Ltd<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/6955:HKG\">HKG: 6955<\/a>) announced a <strong>strategic cooperation agreement<\/strong> with <strong>DP Technology<\/strong> to establish an <strong>AI for Science (AI4S)-driven innovation model<\/strong> combining &#8220;scientific intelligent agents + drug intelligent discovery platform + innovative biological drug development.&#8221; The collaboration targets <strong>antibodies, antibody-drug conjugates (ADCs), and T-cell Engagers (TCEs)<\/strong>, leveraging artificial intelligence to enhance development efficiency and innovation quality across Boan Biotech&#8217;s pipeline.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-partnership-structure\">Partnership Structure<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Element<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Deal Type<\/strong><\/td><td>Strategic cooperation (AI4S-driven drug discovery)<\/td><\/tr><tr><td><strong>Partner 1<\/strong><\/td><td>Boan Biotech (HKG: 6955) \u2013 biologics development &amp; manufacturing<\/td><\/tr><tr><td><strong>Partner 2<\/strong><\/td><td>DP Technology \u2013 AI for Science platform<\/td><\/tr><tr><td><strong>Focus Areas<\/strong><\/td><td>Antibodies, ADCs, TCEs<\/td><\/tr><tr><td><strong>Model<\/strong><\/td><td>&#8220;Scientific intelligent agents + drug discovery platform + novel mechanism biologics&#8221;<\/td><\/tr><tr><td><strong>Announcement Date<\/strong><\/td><td>5\u202fMar\u202f2026<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-core-collaboration-pillars\">Core Collaboration Pillars<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Pillar<\/th><th>Application<\/th><th>Strategic Value<\/th><\/tr><\/thead><tbody><tr><td><strong>\u2460 Large Life Modality Models<\/strong><\/td><td>Antibody drug development<\/td><td>AI-powered antibody design, optimization, and developability prediction<\/td><\/tr><tr><td><strong>\u2461 Computational ADC Development<\/strong><\/td><td>ADC pipeline expansion<\/td><td>In silico payload-linker selection, tumor targeting optimization<\/td><\/tr><tr><td><strong>\u2462 TCE Pipeline Acceleration<\/strong><\/td><td>T-cell engager discovery<\/td><td>Bispecific design, T-cell affinity engineering, safety profiling<\/td><\/tr><tr><td><strong>\u2463 AI4S Innovation Scenarios<\/strong><\/td><td>Cutting-edge exploration<\/td><td>Novel modality identification, mechanism deconvolution<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-rationale\">Strategic Rationale<\/h2>\n\n\n\n<p><strong>Boan Biotech Contributions:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Extensive drug development experience in antibodies, ADCs, and TCEs<\/li>\n\n\n\n<li>Well-established industrialization and GMP manufacturing capabilities<\/li>\n\n\n\n<li>Clinical-stage pipeline requiring optimization and expansion<\/li>\n<\/ul>\n\n\n\n<p><strong>DP Technology Contributions:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Leading AI for Science (AI4S) technology platform<\/li>\n\n\n\n<li>Large-scale molecular simulation and generative AI capabilities<\/li>\n\n\n\n<li>Proven track record in protein structure prediction and drug-target interaction modeling<\/li>\n<\/ul>\n\n\n\n<p><strong>Synergy Value:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Speed:<\/strong> AI-driven candidate selection reduces discovery timelines by estimated 30-40%<\/li>\n\n\n\n<li><strong>Quality:<\/strong> In silico developability assessment reduces late-stage attrition<\/li>\n\n\n\n<li><strong>Novelty:<\/strong> AI-enabled exploration of unconventional antibody architectures and ADC payloads<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-competitive-context\">Competitive Context<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Factor<\/th><th>Market Implication<\/th><\/tr><\/thead><tbody><tr><td><strong>AI4S Adoption<\/strong><\/td><td>China biotech sector accelerating AI integration; DP Technology among leading platform providers<\/td><\/tr><tr><td><strong>ADC\/TCE Competition<\/strong><\/td><td>Global ADC market projected $30B+ by 2030; TCEs gaining traction in solid tumors<\/td><\/tr><tr><td><strong>Differentiation<\/strong><\/td><td>Computational-first approach may yield best-in-class molecules vs. traditional discovery<\/td><\/tr><tr><td><strong>Investor Focus<\/strong><\/td><td>HKG: 6955 shares expected to benefit from AI partnership premium<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-pipeline-impact-amp-outlook\">Pipeline Impact &amp; Outlook<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Near-term:<\/strong> AI-optimized antibody candidates entering IND-enabling studies within 12-18 months<\/li>\n\n\n\n<li><strong>Medium-term:<\/strong> Novel ADCs with computationally-designed linker-payload combinations targeting solid tumors<\/li>\n\n\n\n<li><strong>Long-term:<\/strong> TCE platform addressing autoimmune and oncology indications with AI-refined specificity profiles<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding technology integration timelines, pipeline advancement, and competitive positioning for the Boan Biotech-DP Technology collaboration. Actual results may differ due to AI model performance, technology transfer complexity, and clinical development risks.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Shandong Boan Biotechnology Co., Ltd (HKG: 6955) announced a strategic cooperation agreement with DP Technology&#8230;<\/p>\n","protected":false},"author":1,"featured_media":58918,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[99,220,1024],"class_list":["post-58917","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-ai","tag-boan-biotechnology","tag-hkg-6955"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Boan Biotech Partners with DP Technology on AI4S Drug Discovery \u2013 Antibody, ADC, and TCE Pipeline Acceleration - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Shandong Boan Biotechnology Co., Ltd (HKG: 6955) announced a strategic cooperation agreement with DP Technology to establish an AI for Science (AI4S)-driven innovation model combining &quot;scientific intelligent agents + drug intelligent discovery platform + innovative biological drug development.&quot; The collaboration targets antibodies, antibody-drug conjugates (ADCs), and T-cell Engagers (TCEs), leveraging artificial intelligence to enhance development efficiency and innovation quality across Boan Biotech&#039;s pipeline.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=58917\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Boan Biotech Partners with DP Technology on AI4S Drug Discovery \u2013 Antibody, ADC, and TCE Pipeline Acceleration\" \/>\n<meta property=\"og:description\" content=\"Shandong Boan Biotechnology Co., Ltd (HKG: 6955) announced a strategic cooperation agreement with DP Technology to establish an AI for Science (AI4S)-driven innovation model combining &quot;scientific intelligent agents + drug intelligent discovery platform + innovative biological drug development.&quot; The collaboration targets antibodies, antibody-drug conjugates (ADCs), and T-cell Engagers (TCEs), leveraging artificial intelligence to enhance development efficiency and innovation quality across Boan Biotech&#039;s pipeline.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=58917\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-06T05:25:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/03\/0602.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=58917#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=58917\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Boan Biotech Partners with DP Technology on AI4S Drug Discovery \u2013 Antibody, ADC, and TCE Pipeline Acceleration\",\"datePublished\":\"2026-03-06T05:25:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=58917\"},\"wordCount\":404,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=58917#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/0602.webp\",\"keywords\":[\"AI\",\"Boan Biotechnology\",\"HKG: 6955\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=58917#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=58917\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=58917\",\"name\":\"Boan Biotech Partners with DP Technology on AI4S Drug Discovery \u2013 Antibody, ADC, and TCE Pipeline Acceleration - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=58917#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=58917#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/0602.webp\",\"datePublished\":\"2026-03-06T05:25:11+00:00\",\"description\":\"Shandong Boan Biotechnology Co., Ltd (HKG: 6955) announced a strategic cooperation agreement with DP Technology to establish an AI for Science (AI4S)-driven innovation model combining \\\"scientific intelligent agents + drug intelligent discovery platform + innovative biological drug development.\\\" The collaboration targets antibodies, antibody-drug conjugates (ADCs), and T-cell Engagers (TCEs), leveraging artificial intelligence to enhance development efficiency and innovation quality across Boan Biotech's pipeline.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=58917#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=58917\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=58917#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/0602.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/0602.webp\",\"width\":1080,\"height\":608,\"caption\":\"Boan Biotech Partners with DP Technology on AI4S Drug Discovery \u2013 Antibody, ADC, and TCE Pipeline Acceleration\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=58917#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Boan Biotech Partners with DP Technology on AI4S Drug Discovery \u2013 Antibody, ADC, and TCE Pipeline Acceleration\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Boan Biotech Partners with DP Technology on AI4S Drug Discovery \u2013 Antibody, ADC, and TCE Pipeline Acceleration - Insight, China&#039;s Pharmaceutical Industry","description":"Shandong Boan Biotechnology Co., Ltd (HKG: 6955) announced a strategic cooperation agreement with DP Technology to establish an AI for Science (AI4S)-driven innovation model combining \"scientific intelligent agents + drug intelligent discovery platform + innovative biological drug development.\" The collaboration targets antibodies, antibody-drug conjugates (ADCs), and T-cell Engagers (TCEs), leveraging artificial intelligence to enhance development efficiency and innovation quality across Boan Biotech's pipeline.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=58917","og_locale":"en_US","og_type":"article","og_title":"Boan Biotech Partners with DP Technology on AI4S Drug Discovery \u2013 Antibody, ADC, and TCE Pipeline Acceleration","og_description":"Shandong Boan Biotechnology Co., Ltd (HKG: 6955) announced a strategic cooperation agreement with DP Technology to establish an AI for Science (AI4S)-driven innovation model combining \"scientific intelligent agents + drug intelligent discovery platform + innovative biological drug development.\" The collaboration targets antibodies, antibody-drug conjugates (ADCs), and T-cell Engagers (TCEs), leveraging artificial intelligence to enhance development efficiency and innovation quality across Boan Biotech's pipeline.","og_url":"https:\/\/flcube.com\/?p=58917","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-03-06T05:25:11+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/03\/0602.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=58917#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=58917"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Boan Biotech Partners with DP Technology on AI4S Drug Discovery \u2013 Antibody, ADC, and TCE Pipeline Acceleration","datePublished":"2026-03-06T05:25:11+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=58917"},"wordCount":404,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=58917#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/03\/0602.webp","keywords":["AI","Boan Biotechnology","HKG: 6955"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=58917#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=58917","url":"https:\/\/flcube.com\/?p=58917","name":"Boan Biotech Partners with DP Technology on AI4S Drug Discovery \u2013 Antibody, ADC, and TCE Pipeline Acceleration - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=58917#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=58917#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/03\/0602.webp","datePublished":"2026-03-06T05:25:11+00:00","description":"Shandong Boan Biotechnology Co., Ltd (HKG: 6955) announced a strategic cooperation agreement with DP Technology to establish an AI for Science (AI4S)-driven innovation model combining \"scientific intelligent agents + drug intelligent discovery platform + innovative biological drug development.\" The collaboration targets antibodies, antibody-drug conjugates (ADCs), and T-cell Engagers (TCEs), leveraging artificial intelligence to enhance development efficiency and innovation quality across Boan Biotech's pipeline.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=58917#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=58917"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=58917#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/03\/0602.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/03\/0602.webp","width":1080,"height":608,"caption":"Boan Biotech Partners with DP Technology on AI4S Drug Discovery \u2013 Antibody, ADC, and TCE Pipeline Acceleration"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=58917#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Boan Biotech Partners with DP Technology on AI4S Drug Discovery \u2013 Antibody, ADC, and TCE Pipeline Acceleration"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/03\/0602.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/58917","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=58917"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/58917\/revisions"}],"predecessor-version":[{"id":58919,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/58917\/revisions\/58919"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/58918"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=58917"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=58917"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=58917"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}